BehaVR is a leader in building evidence-based, immersive, digital therapeutics designed to create a more resilient world, liberated from fear and pain. Its suite of clinically validated therapeutics offer access to treatments on a spectrum across mental wellness and mental and behavioral conditions, including validated treatments for serious mental illness. BehaVR is the first immersive digital therapeutics company to deliver these treatments on an integrated platform that simplifies the patient experience, enables clinician oversight, and generates patient-specific care plans and measurable outcomes. Combining a team of accomplished clinicians and researchers with proven healthcare veterans and technology innovators, BehaVR is dedicated to improving access to better mental health through immersive technology.
| Date | Amount | Type | Investors | Valuation |
|---|---|---|---|---|
| 12/13/22 | $13,000,000 | Series B |
Accenture Ventures Chrysalis Ventures Confluent Health Optum Ventures  Oxford Science Enterprises Thornton Capital | undisclosed |
